Secondary Logo

Journal Logo

June 2013 - Volume 39 - Issue 6
pp: 823-965

A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint

William Hanke, C.; Narins, Rhoda S.; Brandt, Fredric; More

Dermatologic Surgery. 39(6):891-899, June 2013.